1 No. KK ELCID 2563/003 November 11, 2020 Subject: Management Discussion and Analysis for the third quarter ended September 30, 2020 To: President The Stock Exchange of Thailand K&K Superstore

(Translation) 1/4 November 16, 2020 Re: Clarification of the operating results of company and its subsidiaries for the nine months period end September 30, 2020 To: President The Stock Exchange of

No. MVP067/2020 November 16, 2020 Subject: Management Discussion and Analysis for the three – month and nine – month periods ended September 30, 2020 To: President and Manager The Stock Exchange of

the 3rd quarter ended 30 September 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 3rd quarter ended 30 September 2019, as submitted by

-Translation- 1 -Translation- Ref. NCH 040/2019 November 8, 2019 Subject : Management’s Discussion and Analysis Q.3/2019 Attention : President The Stock Exchange of Thailand N.C. Housing Plc. (“the

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

- Translation - 11 November 2019 Subject: Management’s Discussion and Analysis for the Operating Results of the 3 rd Quarter of 2019 Attention: The President of the Stock Exchange of Thailand Exotic

Microsoft Word - MD_A_Q3_2019_EN 1 GLOCON.061/2019 November 11th, 2019 Subject Management’s analysis for the 3rd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s